SCHEMBL1185247

SCHEMBL1185247

N#C[n+]1cccc2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACHE P22303 14/20 0.42
BCHE P06276 13/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4103240 0.71 APP (0.41) ACHEBCHE
SCHEMBL1665979 0.69 ACHE (0.46) ACHEBCHE
SCHEMBL9478372 0.68 ACHE (0.38) ACHEBCHE
Water SCHEMBL5786021 0.67 ATM (0.46) ACHEBCHE
SCHEMBL1051965 0.64 ACHE (0.48) ACHEBCHE
SCHEMBL4824142 0.64 ACHE (0.46) ACHEBCHE
SCHEMBL307903 0.64 ACHE (0.53) ACHEBCHE
SCHEMBL8724092 0.64 ACHE (0.46) ACHEBCHE
SCHEMBL3861730 0.64 ACHE (0.46) ACHEBCHE
SCHEMBL7111378 0.64 ACHE (0.46) ACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117980503-A Optical system for nucleic acid sequencing and method thereof 元素生物科学公司 2024-05-03 CN disclosed
CN-117980474-A Engineering polymerase 元素生物科学公司 2024-05-03 CN disclosed
CN-114729400-A Methods for cell addressable nucleic acid sequencing 元素生物科学公司 2022-07-08 CN disclosed
CN-113939601-A Multivalent binding compositions for nucleic acid analysis 元素生物科学公司 2022-01-14 CN disclosed
EP-1499745-B1 CHARACTERIZATION OF SINGLE STRANDED NUCLEIC ACIDS BY MELTING ANALYSIS OF SECONDARY STRUCTURE USING DOUBLE STRAND-SPECIFIC NUCLEIC ACID DYE UNIV UTAH RES FOUND (US) 2016-11-23 EP disclosed
US-8232314-B2 Compounds that protect against sensory hair cell death UNIVERSITY OF WASHINGTON (US) 2012-07-31 US disclosed
US-8148443-B2 Oxonium and sulfonium salts MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-04-03 US disclosed
US-20110034698-A1 Oxonium And Sulfonium Salts IGNATYEV NIKOLAI MYKOLA 2011-02-10 US disclosed
US-7842804-B2 Ionic salts comprising pyrrolidinium, triazolinium, piperidinium or morpholinium cations and alkyltrifluorophosphate anions MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-11-30 US disclosed
US-7524632-B2 Species identification by melting analysis of secondary structure of single stranded nucleic acids UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2009-04-28 US disclosed
WO-2000020222-A1 METHOD FOR MANUFACTURE OF ELECTRONIC PARTS KODAK POLYCHROME GRAPHICS COMPANY LTD. (US) 2000-04-13 WO disclosed
EP-0825927-B1 LITHOGRAPHIC PRINTING FORM PRECURSOR AND ITS USE BY HEAT IMAGING KODAK POLYCHROME GRAPHICS CO (US) 1999-08-11 EP disclosed
WO-1999021715-A1 MANUFACTURE OF LITHOGRAPHIC PRINTING FORMS KODAK POLYCHROME GRAPHICS COMPANY LTD. (US) 1999-05-06 WO disclosed
WO-1999021725-A1 PATTERN FORMATION KODAK POLYCHROME GRAPHICS COMPANY LTD (US) 1999-05-06 WO disclosed
WO-1999008879-A1 METHOD OF MAKING MASKS AND ELECTRONIC PARTS KODAK POLYCHROME GRAPHICS COMPANY LTD. (US) 1999-02-25 WO disclosed
EP-0887182-A1 Heat-sensitive composition and method of making a lithographic printing form with it HORSELL GRAPHIC INDUSTRIES LIMITED (GB) 1998-12-30 EP disclosed
EP-0825927-A1 HEAT-SENSITIVE COMPOSITION AND METHOD OF MAKING A LITHOGRAPHIC PRINTING FORM WITH IT HORSELL GRAPHIC INDUSTRIES LIMITED (GB) 1998-03-04 EP disclosed
WO-1997039894-A1 HEAT-SENSITIVE COMPOSITION AND METHOD OF MAKING A LITHOGRAPHIC PRINTING FORM WITH IT HORSELL GRAPHIC INDUSTRIES LIMITED (GB) 1997-10-30 WO disclosed
US-4396620-A BACTERICIDES ELI LILLY AND COMPANY (US) 1983-08-02 US disclosed
US-4382931-A 3'-Substituted quinolinium cephalosporins ELI LILLY AND COMPANY (US) 1983-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110034698-A1 Oxonium And Sulfonium Salts PRDX2, SCO2, SFXN1 ACHE 4823/4885BCHE 4727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.